This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Therapeutic potential of venom peptides: insights in the nanoparticle-mediated venom formulations
Future Journal of Pharmaceutical Sciences Open Access 15 June 2022
-
Isolation and characterization of Bradykinin potentiating peptides from Agkistrodon bilineatus venom
Proteome Science Open Access 14 January 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Goldblatt, H., Lynch, J., Hanzal, R.F. & Summerville, W.W. Studies on experimental hypertension, I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J. Exp. Med. 59, 347– 379 (1934).
Peart, W.S. Renin-angiotensin system. N. Engl. J. Med. 292, 302–306 (1975).
Skeggs, L.T., Kahn, J.R. & Shumway, N.P. Preparation and function of the hypertensin-converting enzyme. J. Exp. Med. 103, 295– 299 (1956).
Ng, K.K.F. & Vane, J.R. Conversion of angiotensin I to angiotensin II. Nature 216, 762–766 (1967).
Cushman, D.W. & Cheung, H.S. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem. Pharmacol. 20, 1637–1648 ( 1971).
Steitz, T.A., Ludwig, M.L., Quiocho, F.A. & Lipscomb, W.N. The structure of carboxypeptidase A. V. Studies of enzyme-substrate and enzyme-inhibitor complexes at 6 Å resolution. J. Biol. Chem. 242 , 4662–4668 (1967).
Cushman, D.W., Cheung, H.S., Sabo, E.F. & Ondetti, M.A. in Advances in Pharmacology and Therapeutics II vol. 3 (eds. Yoshida, H, Hasihara, Y. & Ebashi, S.) 249–258 (Pergamon, New York, 1982).
Ferreira, S.H., Bartelt, D.C. & Greene, L.J. Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom. Biochemistry 9, 2583–2593 (1970).
Ondetti, M.A., Williams, N.J., Sabo, E.F., Pluscec, J., Weaver, E.R. & Kocy, O. Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis. Biochemistry 10, 4033– 4039 (1971).
Cheung, H.S. & Cushman, D.W. Inhibition of homogeneous angiotensin-converting enzyme of rabbit lung by synthetic venom peptides of Bothrops jararaca . Biochim. Biophys. Acta 293, 451– 463 (1973).
Byers, L.D. & Wolfenden, R. Binding of the biproduct analog benzylsuccinic acid by carboxypeptidase A. Biochemistry 12, 2070–2078 (1973).
Ondetti, M.A., Rubin, B & Cushman, D.W. Design of specific inhibitors of angiotensin-converting enzyme: New class of orally active antihypertensive agents. Science 196, 441–444 ( 1977).
Cushman, D.W., Cheung, H.S., Sabo, E.F. & Ondetti, M.A. Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids. Biochemistry 16, 5484–5491 (1977).
Ondetti, M.A. From peptides to peptidases: A chronicle of drug discovery. Annu. Rev. Pharmacol. 34, 1–16 (1994).
Case, D.B. et al. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin. Am. J. Med. 61, 790–796 (1976).
Monzingo, A.F. & Matthews, B.W. Structure of a mercaptan-thermolysin complex illustrates mode of inhibition of zinc proteases by substrate-analogue mercaptans. Biochemistry 21, 3390–3394 (1982).
Ondetti, M.A. & Cushman, D.W. Angiotensin-converting enzyme inhibitors: Biochemical properties and biological activities. CRC Crit. Rev. Biochem. 16, 381–411 (1984).
Weber, M.A. Comparison of type I angiotensin II receptor blockers and angiotensin-converting enzyme inhibitors in the treatment of hypertension. J. Hypertens. Suppl. 15, S31–S36 ( 1977).
Summers, J.B. & Davidsen, S.K. Matrix Metalloproteinase Inhibitors and Cancer. Ann. Reports Med. Chem. 33, 131–140 (1998).
Burnett, J.C. Jr. Vasopeptidase inhibition: a new concept in blood pressure management. J. Hypertens. 17, S37– 43 (1999).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cushman, D., Ondetti, M. Design of angiotensin converting enzyme inhibitors. Nat Med 5, 1110–1112 (1999). https://doi.org/10.1038/13423
Issue Date:
DOI: https://doi.org/10.1038/13423
This article is cited by
-
Therapeutic potential of venom peptides: insights in the nanoparticle-mediated venom formulations
Future Journal of Pharmaceutical Sciences (2022)
-
In Silico Evaluation of Food Derived Bioactive Peptides as Inhibitors of Angiotensin Converting Enzyme (ACE)
International Journal of Peptide Research and Therapeutics (2021)
-
Melittin: a venom-derived peptide with promising anti-viral properties
European Journal of Clinical Microbiology & Infectious Diseases (2020)
-
Isosteres of hydroxypyridinethione as drug-like pharmacophores for metalloenzyme inhibition
JBIC Journal of Biological Inorganic Chemistry (2018)
-
Identification and Inhibitory Mechanism of Angiotensin I-Converting Enzyme Inhibitory Peptides Derived from Bovine Hemoglobin
The Protein Journal (2017)